Back to News

By Katonah Bedford Veterinary Center
Published: May 08, 2014

Katonah Bedford Veterinary Center congratulates our Oncology Specialist and Director of Clinical Studies for VCA-Antech Dr. Philip J. Bergman and his co-authors Nathan Peterson, DVM, DACVECC and Nicole Buote, DVM, DACVS of VCA West Los Angeles Animal Hospital ( on their published study in the April 2014 Journal of the American Veterinary Medical Association: (Nathan W. Peterson, Nicole J. Buote, and Philip Bergman. Effect of epidural analgesia with opioids on the prevalence of urinary retention in dogs undergoing surgery for cranial cruciate ligament rupture. J Am Vet Med Assoc. 2014 Apr 15;244(8):940-3). To view the abstract, please visit

All of us are very proud of Dr. Bergman for all of his contributions that have helped advance the field of veterinary medicine and provide effective new breakthrough treatments for pets. Among his many achievements, ONCEPT, the first commercially available vaccine for the treatment of melanoma was developed by Dr. Bergman in partnership with Memorial Sloan-Kettering Cancer Center and Merial. It is the first and only USDA-approved, therapeutic vaccine for the treatment of cancer �" in either animals or humans �" and has been shown to significantly extend survival rates of dogs suffering from stage II or stage III oral canine melanoma. Thanks, Dr. Bergman, for your great work!